NeoSoma

Air2Growth

Air2Growth is developing an innovative system that converts CO2 emissions directly on-site into high-quality organic fertilizer. Using advanced microalgae technology, we create a closed circular economy that enables more sustainable, independent, and economical agriculture. Our solution specifically targets greenhouse operators as well as modern agricultural businesses. By directly utilizing exhaust gases and CO2 sources, our customers not only actively lower their environmental footprint, but also noticeably reduce their ongoing fertilizer costs at the same time. In times of fluctuating market prices and uncertain supply chains, Air2Growth makes businesses independent of fossil raw materials and synthetic imports. In this way, we combine effective climate protection with concrete economic benefits and strengthen the future viability of regional food production.

NEENO

NEENO makes human motion data accessible without cameras. Our wearable motion-tracking technology captures how people move in real time and transforms it into precise digital twins. Without studios, complex setups, or expensive infrastructure. We are starting in physiotherapy and healthcare, where professionals need objective, easy-to-use motion measurements to assess patients, track recovery, and make better decisions. But healthcare is just the starting point. The same technology will power sports, biomechanics, industrial applications, and physical AI.

rnhale

RNhale develops inhaled RNA therapeutics for COPD and severe asthma. Our platform transforms RNA-loaded lipid nanoparticles into an inhalable dry powder, enabling direct, local delivery to the lungs. By addressing the key challenges of pulmonary RNA delivery, stability, deep lung deposition, and cellular uptake, our technology unlocks a more effective path for RNA-based therapies to reach their target. Our goal is to develop effective, locally-acting respiratory therapies that address disease at its molecular source. Our vision: to redefine the treatment of severe lung diseases.